Watchlist Price Alert

Theriva Biologics Inc. (TOVX)

AMEX: TOVX · Real-Time Price · USD

0.62

-0.19 (-23.46%)

At close: May 08, 2025, 3:59 PM

0.65

4.90%

Pre-market: May 09, 2025, 08:53 AM EDT

Theriva Biologics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	11.61M	23.18M	41.79M	67.33M	6.23M	15.04M	28.92M	17.12M	19.05M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	99K	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	171K	180K	-3.15M	23K	23K	23K	23K	23K	23K
Receivables	n/a	1.94M	231K	n/a	469K	3K	n/a	46K	185K
Inventory	n/a	n/a	-231K	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	235K	n/a	n/a	n/a	n/a	134K	n/a	n/a	1.68M
Total Current Assets	16.28M	27.4M	45.52M	68.86M	7.93M	16.43M	29.51M	17.94M	21.57M
Property-Plant & Equipment	1.54M	2.18M	1.54M	1.48M	453K	786K	607K	872K	905K
Goodwill & Intangibles	17.36M	25.45M	24.68M	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	19.07M	27.82M	26.34M	1.51M	476K	809K	630K	895K	928K
Total Assets	35.35M	55.22M	71.86M	70.36M	8.41M	17.23M	30.14M	18.84M	22.5M
Account Payables	859K	770K	915K	524K	886K	2.31M	1.03M	2.02M	1.99M
Deferred Revenue	n/a	2.87M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	600K	63K	273K	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	6.13M	3.9M	4.25M	1.93M	n/a	n/a	99K	4.17M	14.82M
Total Current Liabilities	7.58M	6.74M	7.06M	3.55M	2.97M	5.28M	3.38M	9.79M	19.76M
Long-Term Debt	92K	162K	221K	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	8.61M	7.18M	7.21M	n/a	n/a	n/a	302K	402K	492K
Total Long-Term Liabilities	8.7M	8.78M	10.24M	1.4M	186K	473K	302K	12.46M	492K
Total Liabilities	16.29M	15.52M	17.3M	4.96M	3.15M	5.75M	3.69M	22.25M	20.25M
Total Debt	1.56M	2.15M	1.68M	1.53M	473K	722K	n/a	n/a	n/a
Common Stock	3K	18K	16K	132K	29K	17K	15K	129K	117K
Retained Earnings	-334.97M	-309.32M	-290.97M	-271.28M	-248.09M	-235.54M	-219.46M	-194.17M	-172.03M
Comprehensive Income	-1.18M	32K	-679K	n/a	n/a	n/a	0.00	-12.05M	n/a
Shareholders Equity	19.07M	39.7M	54.56M	65.41M	8.03M	14.37M	29.36M	-1.5M	3.85M
Total Investments	n/a	102K	99K	n/a	n/a	n/a	n/a	n/a	n/a